跳至主要内容
临床试验/NL-OMON45631
NL-OMON45631招募中不适用

Psychiatric and cognitive function in patients with Neuroendocrine tumours with carcinoid syndrome. - Psychiatric and cognitive function in patients with NET.

ederlands Kanker Instituut0 个研究点目标入组 85 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
85

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with ileal NET with metastatic disease, diagnosed between 2012 and 2017
  • - Signed informed consent

排除标准

  • - No sufficient understanding of the Dutch language.
  • - A previous cerebro vascular accident (assessed through review of the chart and checked with the patient)
  • - Severe cognitive problems such as a dementia.
  • - Delirium in the past 3 months
  • - Use of 5-HT modulating medication, such as SSRIs or SNRIs, or tryptophan
  • - Current chemotherapy, or chemotherapy in the past 5 years
  • - Previous malignancy in the past 5 years, except for adequately treated basal cell carcinoma of the skin.
  • - Life expectancy shorter than 3 months
  • - Patients with a primary psychotic disorder (schizophrenia)

研究者

发起方
ederlands Kanker Instituut

相似试验